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Abstract 
In the economic policy debate it is often stated that population ageing will lead to huge 
increases in the age-related components of public expenditure – primarily pensions and health 
care. This paper analyses a factor that may, at least partly, alleviate the fear that increased life 
expectancy will accelerate the rise in health-care spending: namely the fact that independent of 
decedent age, the bulk of per capita health-care costs are concentrated in the last years of life 
(the so-called ‘death-related’ costs). It surveys the empirical literature on health economics, 
presenting the main results obtained by studies on the interaction among age, proximity to death 
and health-care expenditure. Based on this analysis, it concludes with certainty that age alone is 
not a good predictor of rises in health-care spending, and that proximity to death must also be 
used as a predictor of health-care expenditure. 
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Introduction 
In the economic policy debate it is often stated that the ageing of the population will lead to 
huge rises in the age-related components of public expenditure – primarily pensions and health 
care.  
As often cited in health economics literature, the per capita health-care costs by age profile 
present a J-shaped curve: after childhood, per capita health-care consumption increases with age 
and its growth rate accelerates for the age groups of those over 65. It is thus easy to infer that 
ageing, in that it increases the share of the population in the older age groups, will generate a 
massive growth of health-care spending. Yet numerous studies have also pointed out that the 
effects of ageing on health-care expenditure (HCE) are much more uncertain than apparent from 
observation of the per capita health-care costs by age profile in a given year.  
From a historical viewpoint, demography has never been a significant driver of health-care 
spending (Oxley & MacFarlan, 1994): the growth of spending has mainly been induced by other 
demand effects (per capita income growth and the extension of coverage by national health 
systems) and most of all by supply factors (technological progress, inflation and the supply-
induced demand effect in a sector where information asymmetries are pervasive). 
Moreover, the concern about the future increase in health-care costs as a result of population 
ageing depends on the use of a static and constant age-related HCE profile (the ‘J curve’). But is 
it theoretically correct to assume the constancy of this profile, or does the age-related pattern 
change according to ageing as well?  
Research shows that the age profile changes for two main demographic reasons: the possible 
improvement in health status following the increase in life expectancy
1 and the fact that the bulk 
of individual lifetime health-care costs are concentrated at the end of life (the so-called ‘death-
related’ costs). Depending on possible changes in health status and on the death-costs 
component, observing at a given point of time that the elderly consume more health-care 
services than the young does not imply that the process of ageing alone – in that it increases the 
share of the elderly in the population – will inevitably lead to increases in health-care spending. 
With regard to the death-costs factor, it has been suggested that there may not be a direct causal 
relationship between ageing and health-care costs. This is because the accelerated rise in costs at 
higher ages may not be a function of age per se, but rather of individual proximity to death, 
since age and death are closely correlated (hence the correlation between age and health-care 
                                                 
1 The various scenarios of changes in health-status following increases in life expectancy are briefly 
summarised in section 4; for a survey see Seshamani (2004). 2 | MICHELE RAITANO 
costs may be – at least in part – a spurious one because of this correlation). The relationship 
between ageing and HCE may therefore be more complex than usually discussed, given that the 
individual cost distribution over time is mainly determined by costs entailed in the last years of 
life, rather than by chronological age (see Brockmann, 2000). Thus the J-shaped age profile 
would not depend on an effective increase in consumption by the elderly, but rather on the 
enormous impact of death costs in the age groups for which the mortality rate is higher. 
Consequently, ageing, increasing life expectancy and diminishing mortality rates should 
postpone the onset of death costs and change the individual, age-related, health-care expenditure 
profile.  
The importance of death costs has considerable consequences for health-cost projections. Given 
that the majority of HCE is concentrated near death, it is not possible to assume that the age 
profile of HCE will remain constant when life expectancy increases. Decreases in age-specific 
mortality rates lead to falls in age-specific costs, because declining mortality rates reduce the 
proportion of high-cost users (i.e. those close to death). The correct assumption may therefore 
be the constancy of the proximity-to-death profile of health-care spending. 
This paper focuses on the impact of death costs on health-care spending. It surveys the empirical 
literature on health economics, presenting the main results obtained by studies on the interaction 
among age, proximity to death and health-care expenditure. It should be pointed out that 
empirical studies have focused mainly on health-care costs; only a few of them have examined 
long-term care as well. Table 1 shows the countries in which the impact of death costs has been 
studied and the kinds of analyses performed.  
Table 1. Countries in which studies on death-related costs have been performed 
Country   Kinds of analyses 
US Descriptive  and  projections 
Canada Descriptive 
Switzerland Econometric 
Germany Econometric,  descriptive and projections 
Italy Descriptive  and  projections 
Spain Descriptive 
Austria Descriptive  and  projections 
UK  Econometric, descriptive and projections 
Denmark Descriptive  and  projections 
The Netherlands  Descriptive and projections 
France Descriptive 
Sweden Descriptive  and  projections 
OECD countries  Projections 
Source: Author’s compilation. 
 
As shown in Table 1, these studies have used different methodologies and can be classified into 
the following three groups: 
•  descriptive studies, which evaluate the evolution of death costs by age at death and the ratio 
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•  econometric studies, which seek to estimate whether age and the length of time to death are 
significant drivers of health-care expenditures; and finally,  
•  projection studies, which aim at calculating the difference between health-care cost 
projections that include or otherwise the death-costs assumption. 
A more elaborate discussion of each kind of study is presented in sections 1, 2 and 3; section 4 
concludes. 
1. Descriptive  studies 
As stated in the introduction, numerous recent empirical studies have shown that the bulk of 
individual lifetime HCE is concentrated in the last years – or months – of life, quite 
independently of the age at which death occurs. Since the seminal paper by Lubitz & Riley 
(1993), all the studies performed in a variety of countries have confirmed this finding, and have 
shown that the ratio between the costs incurred by decedents and survivors (no matter how these 
two groups are defined) is very high and tends to decrease with age. 
The main descriptive studies of the interaction among age, proximity to death and HCE are 
listed in Table 2. It should be noted that most of these studies have been conducted using 
statistical methodologies alone (i.e. they describe the different costs by age and length of time to 
death), without inferring a causal relationship between these variables (see section 2 for the 
analysis of econometric papers that study this causal link).  
Numerous studies are based on the US Medicare sample, which mostly records the acute-care 
costs incurred by patients. Some studies have also sought to analyse the share of long-term costs 
incurred in the terminal phase of life, although this analysis is made more difficult by a shortage 
of data. Descriptive studies usually analyse the per capita costs in the last period of life and their 
link with patient age, and they calculate the ratio between decedent and survivor costs by age 
(see Tables 3 and 4).  
All studies show a rapidly decreasing trend in the ratio by age, even if the estimated size differs 
somewhat. These differences may depend on the sample observed, on the kinds of costs 
examined and on the definition of decedent and survivor. Most of the studies listed in Table 3 
define decedents as individuals who do not survive in a given year,
2 while others (CNAMTS, 
2003 and Seshamani & Gray, 2004a and 2004b) decompose the population by years of time to 
death (suggesting that the impact of death on health-care costs is not restricted to the last year of 
life). In the latter cases, the ratios are between the costs of individuals with different numbers of 
years remaining, which means that they are not strictly comparable to the ratios based on costs 
incurred by decedents and survivors in a given year. Busse, Krauth & Schwartz (2002) do not 
study the effect on spending, but rather the number of hospital admission days by age and length 
of time to death. They find that the oldest decedents (those more that 85 years old) are 
hospitalised for fewer days than younger decedents (also because they have different diseases 
and habits).  
                                                 
2 See for example, Ahn, Garcia & Herce (2005), Cislaghi et al. (2003), Lubitz, Beebe & Baker (1995), 
Calfo, Smith & Zezza (2004) and McGrail et al. (2000). 4 | MICHELE RAITANO 
Table 2. Descriptive studies on the interaction among age, proximity to death and health- 
 care expenditure 
Authors  Publication year  Country studied  Object of analysis 
Calfo, Smith & 
Zezza 
2004 US  (Medicare)  Acute-care costs by age and 
decedent/survivor ratio 
Hoover et al.   2002  US (Medicare)  Acute-care costs by age and 
decedent/survivor ratio 
Hogan et al.  2001  US (Medicare)  Acute-care costs by age and 
decedent/survivor ratio 
Miller 2001  US  (Medicare)  Acute-care costs by age and 
length of time to death 
Spillman & 
Lubitz 
2000 US  (Medicare)  Acute-care and nursing-care 
costs by age and 
decedent/survivor ratio 
Lubitz et al.   1995  US (Medicare)  Acute-care costs by age and 
decedent/survivor ratio 
Lubitz & Riley  1993  US (Medicare)  Acute-care costs by age and 
decedent/survivor ratio 
McGrail et al.  2000  Canada (British Columbia)  Acute-care  and nursing-care 
costs by age and 
decedent/survivor ratio 
Gabriele et al.  2006 Italy  Acute-care costs by age and 
decedent/survivor ratio 
Ahn, García & 
Herce 
2005 Spain  Acute-care costs by age and 
decedent/survivor ratio 
Batljan & 
Lagergren 
2004 Sweden  Health and long-term care 
costs by length of time to death 
Madsen 2004  Denmark  Acute-care costs by age and 
decedent/survivor ratio 
Seshamani & 
Gray 
2004 UK  Acute-care costs by age and 
length of time to death 
Polder & 
Achteberg 
2004 The  Netherlands  Acute-care and nursing home 
care 
CNAMTS 2003  France  Acute-care costs by age and 
decedent/survivor ratio 
Cislaghi et al.  2003  Italy (Tuscany)  Acute-care costs by age and 
decedent/survivor ratio 
Busse, Krauth & 
Schwartz  
2002 Germany  Number of days spent in 
hospital by age and 
decedent/survivor ratio 
Riedel et al.  2002 Austria  Acute-care costs by age and 
decedent/survivor ratio 
Source: Author’s compilation.  THE IMPACT OF MORTALITY-RELATED COSTS ON HEALTH CARE EXPENDITURE | 5 
 
Table 3. Decedent/survivor expenditure ratios for the elderly in some studies 
Authors 
Ahn,  
Garcia
& 
Herce 
(2005) 
CNAMTS 
(2003) 
Cislaghi  
et al. 
(2003) 
Lubitz, 
Beebe 
& 
Baker 
(1995) 
Calfo, 
Smith 
& 
Zezza 
(2003) 
Seshamani 
& Gray 
(2004a)  
McGrail 
et al. 
(2000) 
McGrail  
et al. 
(2000) 
Busse,  
Krauth 
& 
Schwartz
(2002) 
Country Spain  France
1 Italy  US  US  UK
2 Canada
3 Canada
4 Germany
5 
60-64 15.8 45-54 
8.5  15.8  –  8.2  –  – – – 
65-69 11.9 55-64 
3.3  10.0 10.6  12.1  14.6  65 
17.9 
65 
11.9 
65-74 
2.2 
70-74 9.4 65-74 
2.6  7.2 8.6  9.2 17.9  75 
10.4 
75 
6.0  – 
75-79 7.4 75-84 
2.8  4.9 6.8  7.1 20.5  85 
6.2 
85 
2.7 
75-84 
1.6 
80-84 6.3  –  3.2 5.3  5.5  21.9  93 
4.7 
93 
1.9  – 
>85 5.0  1.8 1.9  4.4  4.4 22  –  – >85 
1.3 
All ages  24.1  –  11.5  >65 
6.9 
>65 
6.8  –  – – – 
Notes: 1) Proportion of costs borne by a person dying in the same year to those of a person dying in four years’ time; 
2) ratio between men 1 year from death and men 10 years from death; 3) acute-care costs; 4) nursing care 
costs; 5) quantity data. 
Source: Author’s compilation. 
Gabriele et al. (2006) define a decedent as a person who does not survive a given year and show 
a monotonic and similar decreasing pattern of decedent/survivor hospital-cost ratios in all the 
Italian regions they analysed (Table 4). 
Table 4. Decedent/survivor expenditure ratios for the elderly in some Italian regions 
Age groups  Lombardy  Tuscany  Abruzzo  Puglia 
65-69 10.0  13.1  8.3  8.6 
70-74  7.4 8.9 6.3 6.3 
75-79  5.2 6.1 4.4 4.2 
80-84  3.8 4.1 3.2 3.2 
85-89  2.7 3.0 2.2 1.9 
>90  1.8 1.9 1.4 1.3 
All  ages  13.8 14.0 10.2 11.9 
Source: Gabriele et al. (2006). 
Ratio observation shows clearly that both age and length of time to death influence health-care 
costs. The impact on spending of both variables can be analysed by observing the absolute 
values of costs in the last years of life and in the years far from death. In other words, the 
intention is to determine whether the age-decreasing profile owes more to a reduction in the 
numerator or to an increase in the denominator.  6 | MICHELE RAITANO 
Studies that compare the costs incurred by individuals who die or do not die in a given year at 
different ages (Tables 5 and 6) indicate that death costs decrease by age more rapidly than 
survivor costs increase by age. This suggests that because ageing postpones the onset of the 
more expensive terminal costs, it may reduce the pressure on health-care spending.
3 
Table 5. Hospital-care costs for decedents (last year of life) and survivors in Italy (in Tuscany; 
in Italian lira) 
Age groups  Decedents Survivors  Ratio 
65-69 14,204,366  1,731,419  8.2 
70-74 13,324,191  2,248,742  5.9 
75-79 10,463,283  2,536,991  4.1 
80-84 8,429,667  3,053,476  2.8 
>85 5,566,044  3,114,140  1.8 
All ages  10,509,881      838,010  12.5 
Source: Cislaghi et al. (2002). 
Table 6. Hospital-care costs for decedents (last year of life) and survivors in Austria (in euros)  
  Men Women 
Age groups  Last year of life  Survivors  Ratio  Last year of life  Survivors  Ratio 
65-69 16,456  1,212  13.6  17,230  1,009  17.1 
70-74 15,370  1,466  10.5  15,289  1,296  11.8 
75-79 12,717  1,627  7.8  12,829  1,497  8.6 
80-84 9,762  1,455  6.7  9,841  1,363  7.2 
>85 7,037  1,134  6.2  6,164  1,144  5.4 
Source: Riedel et al. (2002). 
A similar pattern is reported in studies that decompose the population according to years of 
remaining life (see Tables 7, 8 and 9), although Seshamani & Gray (2004a)
4 and Miller (2001) 
find a ∩-shaped death-cost profile by age after the age of 65, rather than a monotonically 
decreasing one, because it increases until the age of 80 and then declines.
5 Yet studies that also 
decompose populations by length of time to death confirm that costs increase steadily in the last 
year of life, although the increase is substantial (independent of age) in the previous years as 
well. This finding suggests that death has a more profound impact on health-care expenditure 
than that observed if only the last year of life is considered (see Table 9). 
 
                                                 
3 These results have also been confirmed for the various Italian regions by Gabriele et al. (2006). 
4 Seshamani & Gray (2004a) use econometric methodology (their paper is discussed in detail in the next 
section), but they also provide some descriptive indicators on the UK sample analysed. 
5 Nevertheless, Seshamani & Gray (2004a) stress that the effects of proximity to death on acute-care costs 
far outweigh the effect of age. Moreover, as previously mentioned, it has to be noted that ratios based on 
costs incurred by decedents and survivors in a given year and ratios based on costs incurred by 
individuals with a different number of years to death (especially those who have a considerable length of 
time to death) are not strictly comparable. THE IMPACT OF MORTALITY-RELATED COSTS ON HEALTH CARE EXPENDITURE | 7 
 
Table 7. Hospital costs by age and length of time to death (in Danish krone)  
Age groups  Last year 
of life 
Surviving more 
than 3 years 
Ratio 
50-59 64.9  6.1  10.6 
60-69 69.4  8.7  8.0 
70-79 58.8  12.2  4.8 
80-89 35.5  14.8  2.4 
>90 18.6  10.3 1.8 
All ages  47.7  10.4  4.6 
Source: Madsen (2004). 
Table 8. Average annual hospital costs by years of time to death (in GPB) 
  Women Men 
Age  1 year prior to 
death 
10 years prior to 
death 
Ratio  1 year prior to 
death 
10 years prior to 
death 
Ratio 
65 3,176  209 15.2  2,460  168 14.6 
70 3,649  212 17.2  2,885  161 17.9 
75 3,977  218 18.2  3,201  156 20.5 
80 4,121  227 18.2  3,369  154 21.9 
85 4,052  240 16.9  3,363  154 21.8 
90 3,765  256 14.7  3,175  156 20.4 
95 3,279  278 11.8  2,817  160 17.6 
Source: Seshamani & Gray (2004a). 
Table 9. Health-care costs by years of time to death (various currencies as noted below) 
  Miller
1  Seshamani 
& Gray
2 
Batljan & Lagergren
3 
Years from 
death  >65 75  85  95  >65  All  ages 
< 1  11,100  13,500  10,700  7,000  4,382  0  52 
2 7,000  8,600  6,900  4,900  917  1  35 
3 4,500  5,100  4,600  3,700  616  2  21 
4 3,800  4,200  4,000  3,200  440  3  17 
5 3,400  3,400  3,600  3,300  354  4  14 
6 3,100  3,000  3,300  3,000  273  5  12 
7 2,800  3,000  2,800  2,800  225  6  9 
8 2,500  2,400  2,800  2,500  197  >6  3 
9 2,300  2,400  2,500  2,400  173  –  – 
10 2,200  1,900  2,200  2,100  154  –  – 
> 10  1,600  –  1,700  1,800  –  –  – 
Notes: 1) US dollars; 2) UK GPB; 3) Swedish Krona. 
Sources: Miller (2001), Seshamani & Gray (2004a and 2004b) and Batljan & Lagergren (2004). 8 | MICHELE RAITANO 
The age-decreasing pattern of terminal health-care costs may depend on various factors: 
different diseases afflicting young and old decedents, different hospitalisation rates by age 
group, more aggressive care given to the young compared with the old, ‘care rationing’ with 
regard to the elderly (the behaviour of doctors changes when they deal with patients of different 
ages) and substitution between health and long-term care for the oldest old. Descriptive analysis 
does not allow a causal inference to be drawn as to which factor most significantly influences 
this pattern. It should be noted, however, that long-term care costs in the last year of life seem to 
increase with age,
6 so that the age-decreasing pattern of terminal health-care costs may be partly 
offset by the age-increasing profile of long-term care costs (see Table 10). But this conclusion 
(i.e. the positive shape of age-linked, long-term care costs) might be (at least partly) reversed if 
it were possible to analyse the effect on long-term costs of a larger number of years of 
remaining life and not just the final year (in the case of long-term care, which is often provided 
informally, it is very difficult to obtain data with which to conduct detailed analyses of the 
interaction among costs, age and length of time to death). 
Table 10. Costs for health and long-term care during the last year of life in the US 
Age groups  Medicare  Non-Medicare sources 
5-74  27,832    9,211 
75-84 26,078  12,451 
>85 18,226  18,689 
Source: Hoover et al. (2002). 
Nevertheless, it should be pointed out that empirical descriptive evidence shows that proximity 
to death is a key driver of HCE, and that it cannot be overlooked when the impact of ageing on 
HCE is analysed. In other words, the J-profile of the age-costs profile seems to depend mainly 
on the impact of per capita costs in the last years of life, rather than on a genuine increase in 
health-care needs by age. 
2. Econometric  studies 
As discussed in the previous section, numerous empirical studies have found that the bulk of 
individual, lifetime health-care expenditures are concentrated in the last period of life. It should 
be borne in mind, however, that the studies presented in section 1 are mainly descriptive. On the 
basis of a sample of the older age groups, they show some indicators for health- (and sometimes 
long-term) care costs disaggregated by survivor status, age and proximity to death. But they do 
not infer a causal link between age, proximity to death and health-care spending. This link can 
only be shown by econometric studies.  
Zweifel, Felder & Meiers (1999) analysed the importance of the death-costs component using 
an econometric methodology. Since their seminal paper, other studies have applied econometric 
methodology to study the relationship among health-care expenditure, age and years of life to 
death (see Table 11). 
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Table 11. Econometric analysis of the interaction among age, proximity to death and health- 
   care expenditure 
Authors  Publication 
year 
Country 
studied 
Estimation 
method 
Results 
Zweifel, Felder & 
Werblow 
2004 Switzerland  Two-part 
model 
Only proximity to death is 
significant. 
Felder, Meiers & 
Schmitt  
2000 Switzerland  Two-part 
model 
HCE increases with proximity to 
death. 
HCE in the last months of life 
decreases with age. 
Zweifel, Felder & 
Meiers 
1999 Switzerland  Heckman 
model 
Only proximity to death is 
significant. 
Gray & 
Seshamani  
2004a England  Two-part 
model with 
panel data 
Age and proximity to death have 
significant effects. 
Gray & 
Seshamani 
2004b England  Two-part 
model 
Age and proximity to death have 
significant effects. 
O’Neill et al.  2000  England  OLS  Only proximity to death is 
significant. 
Brockmann 2000  Germany  OLS  Proximity to death is significant. 
There are negative interactions 
between age- and disease-
specific costs. 
Source: Author’s compilation. 
Their analysis is based on a sample of individuals aged over 65 and enrolled in a Swiss 
insurance fund. A Heckman model was used to estimate the impact of age and proximity to 
death on hospital expenditures, using the last quarters of life as indicators of proximity to death. 
The authors estimated the impact of both the last 8 and the last 20 quarters of life (i.e. the last 2 
and 5 years of life), finding that length of time to death has a highly significant effect on 
hospital costs, while age is not significant at all.  
Zweifel, Felder & Meiers thus proved that, given the large difference in health-care costs 
between survivors and decedents, the positive relationship between age and health-care 
spending depends on a spurious correlation between these two variables induced by the higher 
mortality rates (and then by the onset of death costs) in the older age groups.  
These authors then demonstrate that, once remaining lifetime has been controlled for (at least 
for individuals older than 65), health-care costs do not depend on age: hence it is likely that 
ageing and increased life expectancy do not cause a large increase in spending.  
Intense debate ensued from this seminal paper:
7 some authors argued that issues of econometric 
methodology limited the robustness of the results by Zweifel, Felder & Meiers, while others 
repeated their analysis with new datasets.  
                                                 
7 See Gray & Seshamani (2004a and 2004b), O’Neill et al. (2004) and Zweifel, Felder & Werblow 
(2004). For a technical analysis of the econometric problems raised by Zweifel, Felder & Meiers (1999), 
see Salas & Raftery (2001). 10 | MICHELE RAITANO 
Seshamani & Gray (2004a) pointed out the following problems with the results of Zweifel, 
Felder & Meiers: the sample was relatively small; the quarters of remaining life studied (no 
more than 20) were too few to infer a real link between length of time to death and costs (the 
impact of death costs may therefore have been underestimated); and the quarterly observations 
were used as independent ones, without taking account of the clustering of observations on the 
same individual. Seshamani & Gray then criticised the approach of Zweifel, Felder & Meiers as 
not genuinely longitudinal and used a panel data approach in a truly longitudinal fashion in their 
own studies. 
Seshamani & Gray also criticised the use of the Heckman estimation model. On replicating that 
model with their dataset (derived from the Oxford Record Linkage Study – ORLS – a sample of 
English hospital patients from 1970 to 1999 consisting of more than 100,000 individuals) 
Seshamani & Gray (2004b) then show that neither age nor proximity to death are significant 
drivers of health-care costs.
8 Instead, and confirming the importance of the econometric 
methodology, they use a two-part model,
9 which finds that both variables (age and proximity to 
death) are significant, although it confirms that the latter is the main driver of hospital costs (for 
example, it shows that in the last three years of life hospital-care costs increase sevenfold, while 
they increase by only about 30% between the ages of 65 and 80). 
The results of Seshamani & Gray (2004a and 2004b) clearly confirm the need to incorporate the 
death-costs component in projections of health-care expenditure. Analysing the impact of 
remaining years of life up to 29 years to death (and not just up to 5 years, as in the previous 
studies), they show that length of time to death is highly significant until 15 years to death. They 
suggest that when used, panel data allow a closer link (than that shown by cross-sectional data) 
to be inferred between hospital costs and years of remaining life, because panel data record each 
individual’s hospitalisation history. But somewhat contradictory to Zweifel, Felder & Meiers 
(1999), they find that age is not neutral but has a significant impact on hospital costs.  
Moreover, when focusing on the relationship between age and costs in the last period of life, 
Seshamani & Gray show that the link between age and death costs is not monotonic: death costs 
increase with age from 65 to 80 and then decline, mainly because after the age of 80, the 
likelihood of being hospitalised diminishes. Zweifel, Felder & Meiers (1999) instead show age 
neutrality on costs in the terminal phase of life, whereas most empirical studies (outlined in 
section 1) suggest that such costs have an age-decreasing profile. It should be noted, however, 
that more robust econometric papers by Felder, Meiers & Schmitt (2000) and Zweifel, Felder & 
Werblow (2004) have confirmed that age is not a significant driver of survivors’ costs by 
showing an age-decreasing pattern of death costs. 
Thus, an estimation technique even more robust than the one used by Zweifel, Felder & Meiers 
(1999) has shown that the widespread belief that increased life expectancy will generate higher 
hospital expenditure is based on a misunderstanding of the real link among age, length of time 
to death and health-care costs. 
That being said, it should be pointed out that such econometric studies analyse only the hospital 
component of health-care costs and overlook other components of health care (i.e. drugs) and 
                                                 
8 They observe that the Heckam model is affected by multi-collinearity problems, so that the impact of 
the independent variables is very often found to be insignificant.  
9 The two-part estimation model of hospital care costs in analysis, using a probit model, initially consists 
of the probability of being hospitalised in a certain period; then, if the probability is positive, the analysis 
involves estimating (by means of an ordinary least squares (OLS) method) the amount of costs incurred 
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long-term care. These other components (which, it should be noted, are less important in terms 
of expenditure) may reveal a different link between age and proximity to death. 
As previously stated, Zweifel, Felder & Werblow (2004) have confirmed the dependence on the 
sample studied by applying a two-part model to their original Swiss dataset (to avoid multi-
collinearity problems). They repeated the Zweifel, Felder & Meiers (1999) estimation and again 
found that the only significant driver of health-care costs is proximity to death, while age does 
not appear to have a significant impact on hospital spending. This conclusion has been 
confirmed by an econometric study based on an English sample (different from the ORLS) 
conducted by O’Neill et al. (2000), who applied a simple OLS method to hospital costs 
disaggregated for age and survivor status (where decedents are defined as individuals in their 
last year of life). 
Interesting results have been obtained by Brockmann (2000), whose analysis focuses on a 
sample of two German Länder hospitals. It confirms that proximity to death is the main driver 
of the hospital component of health-care costs, and also finds a negative relationship between 
costs related to the last year of life and age. In particular, it shows that the hospital costs in the 
last year of life of a 90-year-old are about 55% lower than those of a 65-year-old. 
This negative relationship may depend on various factors: different (and less expensive) 
diseases suffered by the oldest old; different hospitalisation rates by age (because the elderly 
prefer long-term care to hospital care); and an age rationing of hospital care (i.e. doctors prefer 
to devote scarce resources to the young, whose life value is higher, or apply less intensive 
medical treatments to the elderly).  
Brockmann (2000) confirms the hypothesis of age rationing by finding a negative relationship 
even in a multivariate econometric analysis that controls for the type of disease. In other words, 
in their last year of life, the oldest old patients receive less costly treatment than younger 
patients with the same illness. Given this result, the consequences of ageing may be even less 
severe than is commonly assumed. If ageing postpones the onset of death-related costs at higher 
ages, and if such costs decrease with age, increased life expectancy may reduce the death-costs 
component, which, as widely confirmed by both descriptive and econometric empirical studies, 
accounts for the largest share of individual, lifetime health-care costs and is the main driver of 
the link between age and HCE. 
In concluding this section, it should be noted that all econometric studies agree that proximity to 
death, rather than age is the main demographic driver of health-care costs (i.e. of hospital-care 
costs), although there is general disagreement on the effect of age once proximity to death has 
been controlled for. Moreover, when the time span is increased (see Seshamani & Gray’s 
studies) and decedents are not arbitrarily defined as those in their last year of life, proximity to 
death is highly significant even in years far from death. In other words, the impact of death on 
HCE is underestimated if the focus is only on individual spending in the last year of life. 
As regards the impact of age on death costs, while some studies find some sort of age neutrality, 
others find that death costs decrease with age, owing to the age rationing of hospital care, while 
still others report a ∩-shaped relationship between death costs and age in the over-65 age 
groups. It should be recognised that the effects of death costs and their age profile may be very 
different when applied to long-term care. But since adequate data are not available, an 
econometric study analysing the link among age, length of time to death and long-term care 
expenditure has not yet been published. 12 | MICHELE RAITANO 
3. Projection  studies 
The standard methodology used to project the impact of ageing on health-care spending 
combines a static, age-related per capita expenditure profile (the so-called ‘J curve’, derived in 
one instant of time) with demographic projections of the future size of each age group. In that it 
is based on a constant age-related expenditure profile, this methodology does not take account 
of possible improvements in health status, the impact of death-related costs or the effects of 
non-demographic drivers of health-care spending (i.e. technical progress, GDP growth rate and 
inflation in the health sector, especially for drugs).  
When analysing the size of the demographic driver, one cannot overlook the expected effects on 
spending exerted by changes in the health status of the population following the ageing process 
or by the component of death costs. Moreover, use of a static age profile does not allow account 
to be taken of these two effects, and it may probably lead to overestimation of the effect of 
ageing on HCE. 
A static link between age and individual health-care costs implies that death costs do not matter 
and that, even if life expectancy increases, the care needs of each individual do not change. In 
other words, it implies that every further year of life is spent in bad health, as if the expansion of 
morbidity hypothesis were true, which suggests that growth in life expectancy is not driven by a 
better health status, but by a longer period spent in illness. From an empirical point of view, 
however, two other scenarios appear more plausible:
10 the compression of morbidity scenario 
(the number of years spent in good health increase more than life expectancy) and the dynamic 
equilibrium scenario (every further year of life expectancy is spent in good health, so that if life 
expectancy increases by five years, the care needs of a 75-year-old individual become the same 
as the needs of the previous 70-year-old).  
The second round of health and long-term care expenditure projections, which were due to be 
run by the Ageing Working Group on behalf of the Economic Policy Committee (EPC) at the 
end of 2005, will probably differ from the first round of such projections (see EPC, 2001)
11 by 
taking account of the effects exerted on spending by health status improvement, by individual 
survival status (i.e. death-related costs) and by certain non-demographic drivers. 
This section focuses on the methodology used to project spending with account taken of the 
death-costs effect and on the results of the main projection studies that analyse this effect 
(summarised in Table 12). 
Given that the bulk of individual, lifetime health-care costs are concentrated at the end of life 
(as we saw in sections 1 and 2), and given that mortality rates are higher in the older age groups, 
excluding the relevance of death costs generates an upward bias in the average per capita 
expenditure attributed to these groups owing to the decrease in mortality rates. Consequently, 
when projections are run using a static age-related expenditure profile, and when life expectancy 
is supposed to increase, this bias leads to the overestimation of future aggregate health-care 
spending. It has been accordingly suggested that proximity to death should replace age as the 
indicator of the health status of an elderly population and as a fair basis for predictions (Miller, 
2001). 
                                                 
10 For a survey of different scenarios on expected health-status changes, see the European Commission 
(2005). 
11 It should be pointed out, however, that the EPC (2001) acknowledges the limitations of using a 
methodology based on a constant age-related profile, and different hypotheses are tested for some 
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Table 12. Projection studies of health-care costs including the impact of death costs. 
Authors Publication 
year 
Country 
studied 
Main results 
Breyer & Felder  2004  Germany  Per capita HCE increases in the period 2005-50 from €2,596 to 
€3,217 with a standard projection and to €2,959 with a 
projection that includes death costs. 
Schulz, Leidl & 
Konig 
2004 Germany  Projections for quantity; the number of hospital days increases 
from 172 million in 1998 to 231 million in 2050 with a 
standard projection, and 212 million with a projection that 
includes death costs. 
Miller 2001  US 
(Medicare) 
Standard projection results are 14% higher than those 
including the death-costs assumption. 
Stearns & 
Norton 
2004  US 
(Medicare) 
Standard projection results are 15% higher than those 
including the death-costs assumption. 
Serup-Hansen, 
Wickstrom & 
Kristiansen 
2001 Denmark  In the period 2005-20 HCE will increase by 18.5% with a 
standard projection, and by 15.1% with a projection that 
includes death costs. 
Riedel et al.   2002  Austria  Starting from 2.9% of GDP in 2000, in 2050 hospital costs will 
be 3.79% in the baseline scenario and 3.60% or 3.44% 
(depending on the assumptions made) if death costs are 
included. 
Madsen 2004  Denmark  If death costs are included, projected spending will be 0.75 
percentage points lower than shown by a standard projection. 
Seshamani 2004  UK  Incorporating death costs halves the projected annual growth 
rate of national hospital expenditure (yearly from 0.85% to 
0.42%). 
Polder & 
Achterberg 
2004  The 
Netherlands 
With a standard projection, the annual growth rate of HCE is 
0.6% in 2002-10 and 0.7% in 2010-20, while it is respectively 
0.02 and 0.04 percentage points lower when assuming the 
impact of death costs. 
EPC 2001  The 
Netherlands 
Very significant overestimation occurs in the baseline scenario 
with respect to the death-costs scenario (in 2050 the increase 
will be 0.4 percentage points lower, i.e. from 4.7% in 2000 to 
5.2% or 5.6% in 2050). 
EPC 2001  Sweden  Significant overestimation occurs in the baseline scenario with 
respect to the death-costs scenario (in 2050 the increase will be 
0.3 percentage points lower, i.e. from 6.0% in 2000 to 6.7% or 
7.0% in 2050). 
EPC 2001  Italy  Significant overestimation occurs in the baseline scenario with 
respect to the death-costs scenario (in 2050 the increase will be 
0.3 percentage points lower, i.e. from 4.9% in 2000 to 6.2% or 
6.5% in 2050). 
OECD 2005  OECD 
countries 
Reveals a very significant effect of projections including death 
costs and healthy ageing; on average, in the period 2005-50, 
health-care expenditure will rise from 5.6% to 7.2% in the 
baseline scenario (pure ageing effect) and to 6.1% when death 
costs and healthy ageing are included. 
Note: These projections only analyse health-care costs and do not include long-term care costs. 
Source: Author’s compilation. 14 | MICHELE RAITANO 
A very useful exercise is to project spending by linking individual needs with both age and 
years of remaining life. But projections that include the death-related costs component require 
micro-data that disaggregate individual costs per age and years of remaining life, and these data 
(even if based on a sample) are not always available.
12 
Moreover, when such data are available, individuals are often not classified by the number of 
remaining years, but only by their status in a given year, so that those who die in one year are 
defined as decedents, whereas those who survive in that year are defined as survivors. 
Nevertheless, econometric analyses (see Seshamani & Gray, 2004a) show that the impact of 
length of time to death is significant for many years of remaining life. A distinction by survivor 
status based on only one year may therefore underestimate the projected impact of the death-
costs component on HCE. 
The various projection methods applied and the data available may explain the different results 
obtained by the studies set out in Table 12, even though they all report that excluding death 
costs leads to the overestimation of health-care spending. 
Breyer & Felder (2004) apply the costs profile of a Swiss sample (where individuals are sub-
divided into four groups on the basis of their remaining years of life) to German demographic 
forecasts. They show a reduction – of about 20% – in HCE projections when death costs are 
included and point out that the main driver of HCE is technical progress, suggesting that the 
projection error of excluding the death-costs component is very small compared with that of 
excluding the very costly effect of technical progress. 
Schulz & Leidl (2004) divide populations of those with up to three years of remaining life into 
groups and project the number of hospital days for Germany (their projection focuses on 
quantity rather than on spending). Even if they assume constant age morbidity, they find a 
significant reduction in the days projected when the impact of proximity to death is taken into 
account.  
Two other studies (Miller, 2001 and Stearns & Norton, 2004) focus on the US Medicare source 
dataset and show a similar reduction in projected expenditure (about 15%) when death cost 
effects are included. They divide individuals into only two groups (decedents and survivors in a 
given year) and show that the time-to-death projection methodology yields lower expenditure 
than does the standard methodology, but the cost saving is not large enough to offset the strain 
from ageing. A similar, limited expenditure savings is obtained when account is taken of death 
costs for Denmark by Serup-Hansen, Wickstrom & Kristiansen (2001) and for the Netherlands 
by Polder & Achterberg (2004). 
The limited HCE savings in the projections that include death costs do not imply, however, that 
these costs have scant effect. Rather, they can be explained by the huge increase in the share of 
survivors in old age groups. Although at the individual level proximity to death is the main 
driver of health-care spending (as proved by econometric analysis), in the aggregate, ageing 
may induce an increase in spending. If per capita survivor costs are age-increasing, given that 
the share of survivors in the population is much greater than the share of decedents because 
longer life expectancy increases the share of old survivors, it may induce an aggregate 
expenditure growth that cannot be offset by including death costs in projections. 
Yet, other studies in Table 12 report that incorporating the death-costs component into health-
care projections has a relatively significant effect (see also Riedel et al., 2002). Madsen (2004) 
                                                 
12 Data disaggregated for survivor status are even more difficult to collect for long-term care. All the 
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demonstrates that if the population is decomposed into four age groups by number of years of 
remaining life, the inclusion of death costs reduces the increase of HCE by 0.75 of a percentage 
point. Seshamani (2004), on dividing the population into numerous groups according to years of 
remaining life, shows that excluding this component generates estimates of future health-care 
costs that have a sharp upward bias (the annual growth rate of national hospital expenditure 
decreases from 0.85% to 0.42% when death costs are taken into account). She suggests that the 
standard forecasting approach is biased and not useful because it does not consider the dynamic 
effect of ageing. 
In an OECD (2005) study, the HCE increase is split into two different components: the pure 
ageing effect (i.e. the standard methodology) and the effects deriving from a non-static age-
consumption profile (i.e. the death-costs component plus a dynamic equilibrium assumption). 
Based on an average of 30 OECD countries, the study reveals that public HCE will rise from 
5.6% in 2005 to 7.2% in 2050 if a static age profile is assumed and to 6.1% if the age profile is 
assumed to vary owing to death costs and healthy ageing. This finding confirms that while pure 
ageing has a positive impact on the expenditure increase, the inclusion of other demographic 
effects (death costs and morbidity changes) has a negative impact and can (at least partly) offset 
the effect of ageing on HCE. 
The EPC (2001) analysis offers an optional projection that analyses the effect of death costs on 
spending in three countries – Italy, Sweden and the Netherlands – and confirms that standard 
projections significantly overestimate the impact of ageing on HCE. But the EPC used different 
methodologies for these optional projections. Whereas forecasts for Italy and the Netherlands 
were based on splitting the costs between those surviving for a certain period (one year) and 
those dying in that period (for each age class individuals were divided into two groups – 
survivors and decedents), the projections for Sweden were based on a more detailed breakdown 
of the population by years of remaining life (six groups of individuals per each age group were 
selected on the basis of their length of time to death and individuals at least six years of 
remaining life were defined as survivors).  
Essentially, as noted, there are two main methodologies with which to include death costs in 
health-care projections and to extend the standard approach, where the population is 
decomposed only by age and gender and the derived age profile is linked to demographic 
forecasts. The first is based on the decomposition of the population in each cohort into only two 
groups – survivors and decedents in a certain period (usually one year) – to which different cost 
profiles are applied. The second methodology, which requires more specific data, decomposes 
the population into numerous groups
13 according to years of time to death, without restricting 
the effect of death costs to an arbitrarily chosen number of years of remaining life (i.e. one 
year).  
Both approaches estimate the costs for each group (which are kept constant in the projection 
period) and assume that the share of each group in every age cohort evolves in line with 
mortality rates. Thus each cohort’s average health-care costs become the weighted average of 
the various groups’ costs, the amount of which amount changes with variations in life 
expectancy.
14 
                                                 
13 See Batljan & Lagergren (2004), who decompose the population (based on a Swedish sample) into 
seven groups, from those having no years left to live to those with more than six years of remaining life.  
14 Given the lack of data with which to calculate each group’s costs (i.e. specific costs for decedents or for 
years of remaining life), RGS (2004) has proposed that direct costs should not be included in the model 
but rather a coefficient expressing the proportion between the costs borne by non-survivors and those 16 | MICHELE RAITANO 
Obviously, given the empirical evidence that costs prior to death not only increase in the last 
year of life but also in the previous years, disaggregating the data on individuals on the sole 
basis of one year to death may lead to the underestimation of the savings induced by the death-
costs component. Yet data that differentiate the population by those with only one year of 
remaining life are usually more easily available than data that break down the population by 
many years of remaining lifetime. 
In both methodologies, the cost profile by age is not constant but evolves in line with the 
mortality rate, i.e. in line with the evolution of the share between decedents and survivors in 
each age group or with the increase in the average length of time to death. The first method has 
an arbitrary element because it is obliged to assume a specific period of time (i.e. one year) in 
order to classify individuals as decedents or survivors, while the second approach does not 
suffer from this limitation but requires much more detailed data. 
To solve the problem of obtaining data linking per capita health-care costs to years of remaining 
life, Madsen (2004) has proposed the so-called ‘half-longevity correction method’, which 
allows a rough estimation of death costs even when there are no data linking costs to survivor 
status. He notes that if a ‘full-longevity correction method’ is used, it is possible to fix costs for 
years to death (so that if at age 70 life expectancy increases from 7 to 12 years, one can impute 
to a 75-year-old individual the cost profile of a previous 70-year-old one). Yet the effect of age 
on health-care costs – even if less significant, it is still a driver of HCE (Seshamani & Gray, 
2004a) – is thus entirely ignored.  
In the half-longevity correction method, both age and remaining life are assumed to be drivers 
of HCE with equal 50% weights: thus, in the previous example, the 75-year-old’s costs become 
those of the 72.5-year-old. Madsen (2004) states that although this method is arbitrary, it is 
sensible because it empirically gives the same projection results as derived by splitting each age 
cohort into four groups based on the length of remaining lifetime.  
It is notable that projection studies also confirm that age alone is not a good basis for predicting 
the effects of ageing on health-care spending. In all the studies surveyed, projections that 
include time to death yield lower expenditure increases than standard ones, but this does not 
offset the impact of ageing. 
It should also be pointed out that the differences among results may depend on the methodology 
used to incorporate the death-costs assumption and the sample on which the estimation of death 
costs is made. Even depending on the data availability, however, there is still no broad 
consensus on how that assumption can be included. 
 
                                                                                                                                               
borne by survivors in a given age-gender cohort. Direct costs can thus be replaced by a coefficient (or 
more than one coefficient if groups with many years to death are considered), which can be empirically 
estimated in some countries and used for projections in other member states where data are not available, 
on the assumption that the ratio between the decedent’s and survivor’s costs is constant in the various 
states. For example, the Italian optional projection in EPC (2001) was based on the estimation of this ratio 
using a sample derived from Tuscan hospitals by Cislaghi et al. (2003).  
 THE IMPACT OF MORTALITY-RELATED COSTS ON HEALTH CARE EXPENDITURE | 17 
 
4. Conclusions 
Starting from concerns that health-care costs may grow exponentially owing to population 
ageing, this paper has analysed a factor that may, at least partly, alleviate the fear that increased 
life expectancy will accelerate the rise in health-care spending: namely the fact that independent 
of decedent age, the bulk of per capita health-care costs are concentrated in the last years of life 
(the ‘death-related’ costs). 
In the recent literature on health economics it is often argued that per capita costs by age profile 
may not depend on an effective increase in consumption by the elderly, but rather on the huge 
impact of death costs in those age groups where the mortality rate is highest.  
This study has surveyed such literature in order to evaluate the importance of proximity to death 
and age as drivers of health spending. It has classified the empirical literature into three kinds of 
studies: descriptive (which observe the differences in costs between survivors and decedents), 
econometric (which seek to determine a causal link among age, length of time to death and 
spending) and projections (which compare forecasts including or otherwise the death-costs 
component). 
Descriptive studies show that decedent costs are much higher than survivor costs. The ratio 
between the expenditures of these two groups on health care has an age-decreasing character, as 
do the costs in the last period of life. A different age pattern can be observed in long-term care, 
however, despite the fact that a shortage of data has led to a paucity of studies that also analyse 
long-term care. 
Econometric studies confirm that proximity to death, rather than age, is the main driver of 
health-care spending, at least for the over-65 age groups. Yet there is still disagreement on the 
effect of age, once time to death has been controlled for (as well as on the different 
methodologies used by certain authors). Some studies show an ‘age neutrality’ of death costs; 
others suggest a constant age-decreasing profile; and still others report a ∩-shaped relationship 
between age and health-care costs in the last period of life. 
At the individual level, the major importance of death costs is confirmed. Projection studies 
include the differences in per capita costs between survivors and decedents (although they use 
different methods to define these groups) and seek to predict the growth in aggregate health-care 
spending related to ageing. The amount of the reduction in spending once death costs have been 
included in the projection differs significantly among studies, but they all confirm that including 
death costs reduces the concern that health-care spending will increase exorbitantly in the 
future. It can consequently be concluded with certainty that age alone is not a good predictor of 
rises in health-care spending, and that proximity to death must also be used as a predictor of 
health-care expenditure. 
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